Halley E. Gilbert - 31 May 2023 Form 4 Insider Report for Arcutis Biotherapeutics, Inc. (ARQT)

Role
Director
Signature
/s/ Scott Burrows, as Attorney-in-Fact for Halley Gilbert
Issuer symbol
ARQT
Transactions as of
31 May 2023
Net transactions value
$0
Form type
4
Filing time
02 Jun 2023, 19:08:02 UTC
Previous filing
17 Jun 2022
Next filing
15 Jun 2023
SEC
View on sec.gov

Key filing fact

Halley E. Gilbert filed Form 4 for Arcutis Biotherapeutics, Inc. (ARQT) on 02 Jun 2023.

Key facts

  • This page summarizes Halley E. Gilbert's Form 4 filing for Arcutis Biotherapeutics, Inc. (ARQT).
  • 2 reported transactions and 1 derivative row are listed below.
  • Filing timestamp: 02 Jun 2023, 19:08.

Change

  • Previous filing in this sequence was filed on 17 Jun 2022.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reported transactions

ARQT transaction

Common Stock

Award

Transaction value
$0
Shares
+4,375
Change %
+101%
Price
$0.000000
Shares after
8,687
Date
31 May 2023
Ownership
Direct
Footnotes
F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

ARQT transaction Derivative

Stock Option (right to buy)

Award

Transaction value
$0
Shares
+12,220
Change %
Price
$0.000000
Shares after
12,220
Date
31 May 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
12,220
Exercise price
$7.51
Footnotes
F2
An asterisk next to the price means the reported price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 4,375 Restricted Stock Units (?RSUs?). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof.
F2 The underlying shares subject to the option vest and become exercisable as to 100% on the first anniversary of May 31, 2023.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .